CI
BIIB icon

Cordant Inc’s Biogen BIIB Stock Holding History

Cordant Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327 Buy
+2
New +$383 ﹤0.01% 226
2022
Q2 		– Sell
-25
Closed -$5K – 200
2022
Q1 		$5K Buy
+25
New +$5.44K ﹤0.01% 247

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cordant Inc's BIIB Position: Q2 2026 in Review

Cordant Inc opened a new position in Biogen (BIIB) in Q2 2026: 2 shares worth $327. The stake represents ﹤0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Cordant Inc previously reported a position in BIIB as recently as Q1 2022.

Cordant Inc first reported a position in BIIB in Q1 2022 and has held it in 2 quarters since. The position peaked at $5K in Q1 2022. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Cordant Inc held 2 shares of Biogen worth $327 as of Q2 2026.
  • Biogen was a new Cordant Inc position in Q2 2026.
  • Biogen made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #226 holding.
  • Cordant Inc first reported a position in Biogen in Q1 2022 and has held it in 2 quarters since.
  • Cordant Inc's Biogen position peaked at $5K in Q1 2022.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.